Key Takeaways
- Itafos reported full-year 2025 revenues of $558 million, representing a 14% increase compared to 2024's $491.2 million.
- The company achieved production records at both its Conda and Arraias facilities during 2025 while maintaining industry-leading operating rates in the US market.
- Adjusted EBITDA for 2025 was $158.7 million, down slightly from $159.5 million in 2024, primarily due to higher sulfur and sulfuric acid input costs.
- CEO David Delaney expects phosphate prices to improve through the first half of 2026 due to Middle East supply chain disruptions and ongoing Chinese export restrictions.
- The company projects 2026 sales volumes of 335-355 thousand tonnes P2O5 and has budgeted $63-83 million for growth capital expenditures.
Itafos Delivers Strong Financial Performance Despite Cost Pressures
Itafos Inc. (TSX-V: IFOS) (OTCQX: ITFS) reported its fourth quarter and full-year 2025 financial results, demonstrating resilient operational performance amid challenging market conditions. The Houston-based phosphate producer achieved net income of $116.1 million for 2025, compared to $87.8 million in 2024, with basic earnings reaching C$0.84 per share.
“We are pleased to report another quarter and year of successful operating results for the Company. We set Itafos production records at both Conda and Arraias during the year while maintaining US industry-leading operating rates,” said David Delaney, Chief Executive Officer at Itafos.
Production Records Achieved at Key Facilities
The company's Conda facility in Idaho and Arraias operation in Brazil both achieved production milestones during 2025. Itafos invested $79.9 million in total capital expenditures for the year, focusing on the magnesium oxide reduction project at Conda and the Fertilizer Restart Program at Arraias. The company completed a preliminary economic assessment at Arraias supporting plans to produce Single Superphosphate to meet Brazilian market demand.
